ESR1 and breast carcinoma: The activation of ERα results in increased expression of thePI3K/AKT/NF-κB signaling pathway, leading to tumor invasion and metastasis in breast cancer [12].Larger exposure to progesterone hormone increases risk of breast cancer [13].